Commission Delegated Regulation (EU) 2022/1644 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof.

This Regulation compels the Member States to control the use of pharmacologically active substances authorized as veterinary medicinal products or as feed additives and the presence of prohibited or unauthorized pharmacologically active substances and residues thereof listed in Annex I. The Member States shall also control combinations of substance groups and commodity groups and adopt a sampling strategy in accordance with Annexes to this Regulation for national risk-based control plans for production in the Member States, national randomized surveillance plans for production in the Member States, and national risk-based control plans for third country imports, as specified in Regulation (EU) 2022/1646. It also states that the references to Annexes II and III to Directive 96/23/EC shall be construed as references to this Regulation.